• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

OSNA列线图在伴有大转移灶前哨淋巴结患者中的应用:准确性的回顾性评估

Application of OSNA Nomogram in Patients With Macrometastatic Sentinel Lymph Node: A Retrospective Assessment of Accuracy.

作者信息

Combi Francesca, Andreotti Alessia, Gambini Anna, Palma Enza, Papi Simona, Biroli Alice, Zaccarelli Stefania, Ficarra Guido, Tazzioli Giovanni

机构信息

Clinical and Experimental Medicine, University of Modena and Reggio Emilia, Modena, Italy.

Division of Breast Surgical Oncology, Department of Medical and Surgical Maternal-Infantile and Adult Sciences, University Hospital of Modena, Modena, Italy.

出版信息

Breast Cancer (Auckl). 2021 May 10;15:11782234211014796. doi: 10.1177/11782234211014796. eCollection 2021.

DOI:10.1177/11782234211014796
PMID:33994790
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8113365/
Abstract

INTRODUCTION

Almost 50% to 70% of patients who undergo axillary lymph node dissection (ALND) because of a single metastatic sentinel lymph node (SLN) have no further metastatic nodes at the axillary histology. On these grounds, the one-step nucleic acid amplification (OSNA) nomogram was designed and validated. As a mathematical model, calculated through tumor size (expressed in millimeters) and CK19 mRNA copy number, it is thought to predict nonsentinel lymph node (NSLN) status. The aim of the study is to verify the diagnostic accuracy of the OSNA nomogram in a group of patients with macrometastatic SLN, with a retrospective analysis.

METHODS

The OSNA nomogram was retrospectively applied to a group of 66 patients with macrometastatic SLN who underwent ALND. The result of the final histology of the axillary cavity was compared to the nomogram prediction. We calculated the prevalence of NSLN metastasis in patients who underwent ALND, sensitivity and specificity, negative and positive predictive value of the nomogram.

RESULTS

In patients with macrometastasis in SLN, the prevalence of patients with metastatic NSLN was 45%. The sensitivity of the nomogram was excellent (90%). The specificity was low (36%). Positive predictive value amounted to 54%, while negative predictive value was good (81%).

CONCLUSIONS

These results suggest that the OSNA nomogram is a valid instrument that can help choose the best surgical strategy for the treatment of axillary cavity. The mathematical model is useful to avoid surgery in a selected group of patients because it accurately predicts NSLN status.

摘要

引言

因单个前哨淋巴结(SLN)转移而接受腋窝淋巴结清扫术(ALND)的患者中,近50%至70%在腋窝组织学检查中没有其他转移淋巴结。基于这些原因,设计并验证了一步核酸扩增(OSNA)列线图。作为一种通过肿瘤大小(以毫米表示)和CK19 mRNA拷贝数计算得出的数学模型,它被认为可以预测非前哨淋巴结(NSLN)状态。本研究的目的是通过回顾性分析来验证OSNA列线图在一组伴有大转移灶的SLN患者中的诊断准确性。

方法

对一组66例伴有大转移灶的SLN且接受了ALND的患者进行回顾性应用OSNA列线图。将腋窝腔最终组织学检查结果与列线图预测结果进行比较。我们计算了接受ALND患者中NSLN转移的患病率、列线图的敏感性和特异性、阴性和阳性预测值。

结果

在SLN发生大转移的患者中,NSLN转移患者的患病率为45%。列线图的敏感性极佳(90%)。特异性较低(36%)。阳性预测值为54%,而阴性预测值良好(81%)。

结论

这些结果表明,OSNA列线图是一种有效的工具,可有助于选择腋窝腔治疗的最佳手术策略。该数学模型有助于避免对部分患者进行手术,因为它能准确预测NSLN状态。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3618/8113365/a508265a05f4/10.1177_11782234211014796-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3618/8113365/a508265a05f4/10.1177_11782234211014796-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3618/8113365/a508265a05f4/10.1177_11782234211014796-fig1.jpg

相似文献

1
Application of OSNA Nomogram in Patients With Macrometastatic Sentinel Lymph Node: A Retrospective Assessment of Accuracy.OSNA列线图在伴有大转移灶前哨淋巴结患者中的应用:准确性的回顾性评估
Breast Cancer (Auckl). 2021 May 10;15:11782234211014796. doi: 10.1177/11782234211014796. eCollection 2021.
2
Nomogram to predict non-sentinel lymph node status using total tumor load determined by one-step nucleic acid amplification: first report from Thailand.应用一步法核酸扩增检测总肿瘤负荷预测非前哨淋巴结状态的列线图:来自泰国的首次报告。
Breast Cancer. 2019 Jul;26(4):471-477. doi: 10.1007/s12282-019-00945-8. Epub 2019 Jan 7.
3
Nomogram including the total tumoral load in the sentinel nodes assessed by one-step nucleic acid amplification as a new factor for predicting nonsentinel lymph node metastasis in breast cancer patients.列线图将通过一步核酸扩增评估的前哨淋巴结中的总肿瘤负荷作为预测乳腺癌患者非前哨淋巴结转移的新因素。
Breast Cancer Res Treat. 2014 Sep;147(2):371-80. doi: 10.1007/s10549-014-3108-2. Epub 2014 Aug 28.
4
One Step Nucleic Acid Amplification (OSNA) positive micrometastases and additional histopathological NSLN metastases: Results from a single institution over 53 months.一步核酸扩增(OSNA)检测出的微转移灶及其他组织病理学证实的前哨淋巴结转移灶:来自一家机构53个月的研究结果
Surgeon. 2016 Apr;14(2):76-81. doi: 10.1016/j.surge.2014.06.001. Epub 2014 Nov 1.
5
Intraoperative Nomograms, Based on One-Step Nucleic Acid Amplification, for Prediction of Non-sentinel Node Metastasis and Four or More Axillary Node Metastases in Breast Cancer Patients with Sentinel Node Metastasis.基于一步法核酸扩增的术中列线图预测前哨淋巴结转移的乳腺癌患者非前哨淋巴结转移和四个或更多腋窝淋巴结转移的风险。
Ann Surg Oncol. 2018 Sep;25(9):2603-2611. doi: 10.1245/s10434-018-6633-0. Epub 2018 Jul 5.
6
Total tumor load assessed by one-step nucleic acid amplification assay as an intraoperative predictor for non-sentinel lymph node metastasis in breast cancer.通过一步核酸扩增检测评估的肿瘤总负荷作为乳腺癌非前哨淋巴结转移的术中预测指标。
Breast. 2017 Apr;32:33-36. doi: 10.1016/j.breast.2016.12.011. Epub 2016 Dec 25.
7
Intraoperative prediction of the two axillary lymph node macrometastases threshold in patients with breast cancer using a one-step nucleic acid cytokeratin-19 amplification assay.使用一步核酸细胞角蛋白-19扩增检测法对乳腺癌患者腋窝淋巴结大转移阈值进行术中预测。
Mol Clin Oncol. 2017 Nov;7(5):755-762. doi: 10.3892/mco.2017.1404. Epub 2017 Sep 1.
8
Elaboration of a nomogram to predict nonsentinel node status in breast cancer patients with positive sentinel node, intraoperatively assessed with one step nucleic amplification: Retrospective and validation phase.制定用于预测前哨淋巴结阳性的乳腺癌患者非前哨淋巴结状态的列线图:术中采用一步核酸扩增法进行评估,回顾性研究及验证阶段。
J Exp Clin Cancer Res. 2016 Dec 8;35(1):193. doi: 10.1186/s13046-016-0460-6.
9
Comparative validation of online nomograms for predicting nonsentinel lymph node status in sentinel lymph node-positive breast cancer.预测前哨淋巴结阳性乳腺癌非前哨淋巴结状态的在线列线图的比较验证
Arch Surg. 2011 Sep;146(9):1035-40. doi: 10.1001/archsurg.2011.201.
10
MRI-Based Radiomics Nomogram: Prediction of Axillary Non-Sentinel Lymph Node Metastasis in Patients With Sentinel Lymph Node-Positive Breast Cancer.基于MRI的影像组学列线图:前哨淋巴结阳性乳腺癌患者腋窝非前哨淋巴结转移的预测
Front Oncol. 2022 Feb 28;12:811347. doi: 10.3389/fonc.2022.811347. eCollection 2022.

本文引用的文献

1
Nomogram to predict non-sentinel lymph node status using total tumor load determined by one-step nucleic acid amplification: first report from Thailand.应用一步法核酸扩增检测总肿瘤负荷预测非前哨淋巴结状态的列线图:来自泰国的首次报告。
Breast Cancer. 2019 Jul;26(4):471-477. doi: 10.1007/s12282-019-00945-8. Epub 2019 Jan 7.
2
Intraoperative prediction of the two axillary lymph node macrometastases threshold in patients with breast cancer using a one-step nucleic acid cytokeratin-19 amplification assay.使用一步核酸细胞角蛋白-19扩增检测法对乳腺癌患者腋窝淋巴结大转移阈值进行术中预测。
Mol Clin Oncol. 2017 Nov;7(5):755-762. doi: 10.3892/mco.2017.1404. Epub 2017 Sep 1.
3
Highlights from the 15th St Gallen International Breast Cancer Conference 15-18 March, 2017, Vienna: tailored treatments for patients with early breast cancer.
2017年3月15日至18日于维也纳举行的第15届圣加仑国际乳腺癌大会亮点:早期乳腺癌患者的个体化治疗。
Ecancermedicalscience. 2017 Apr 7;11:732. doi: 10.3332/ecancer.2017.732. eCollection 2017.
4
Elaboration of a nomogram to predict nonsentinel node status in breast cancer patients with positive sentinel node, intraoperatively assessed with one step nucleic amplification: Retrospective and validation phase.制定用于预测前哨淋巴结阳性的乳腺癌患者非前哨淋巴结状态的列线图:术中采用一步核酸扩增法进行评估,回顾性研究及验证阶段。
J Exp Clin Cancer Res. 2016 Dec 8;35(1):193. doi: 10.1186/s13046-016-0460-6.
5
Elaboration of a nomogram to predict non sentinel node status in breast cancer patients with positive sentinel node, intra-operatively assessed with one step nucleic acid amplification method.制定一种列线图,用于预测前哨淋巴结阳性的乳腺癌患者非前哨淋巴结状态,术中采用一步核酸扩增法进行评估。
J Exp Clin Cancer Res. 2015 Nov 4;34:136. doi: 10.1186/s13046-015-0246-2.
6
Nomogram including the total tumoral load in the sentinel nodes assessed by one-step nucleic acid amplification as a new factor for predicting nonsentinel lymph node metastasis in breast cancer patients.列线图将通过一步核酸扩增评估的前哨淋巴结中的总肿瘤负荷作为预测乳腺癌患者非前哨淋巴结转移的新因素。
Breast Cancer Res Treat. 2014 Sep;147(2):371-80. doi: 10.1007/s10549-014-3108-2. Epub 2014 Aug 28.
7
Prediction of non-sentinel lymph node metastasis in early breast cancer by assessing total tumoral load in the sentinel lymph node by molecular assay.通过分子检测评估前哨淋巴结中总肿瘤负荷预测早期乳腺癌中的非前哨淋巴结转移。
Eur J Surg Oncol. 2013 Jul;39(7):766-73. doi: 10.1016/j.ejso.2013.03.011. Epub 2013 Apr 19.
8
Intraoperative molecular analysis of total tumor load in sentinel lymph node: a new predictor of axillary status in early breast cancer patients.前哨淋巴结中总肿瘤负荷的术中分子分析:早期乳腺癌患者腋窝状态的新预测指标。
Breast Cancer Res Treat. 2013 May;139(1):87-93. doi: 10.1007/s10549-013-2524-z. Epub 2013 Apr 11.
9
Axillary dissection versus no axillary dissection in patients with sentinel-node micrometastases (IBCSG 23-01): a phase 3 randomised controlled trial.腋窝清扫与前哨淋巴结微转移患者不进行腋窝清扫(IBCSG 23-01):一项 3 期随机对照试验。
Lancet Oncol. 2013 Apr;14(4):297-305. doi: 10.1016/S1470-2045(13)70035-4. Epub 2013 Mar 11.
10
Incorporation of sentinel lymph node metastasis size into a nomogram predicting nonsentinel lymph node involvement in breast cancer patients with a positive sentinel lymph node.将前哨淋巴结转移灶大小纳入预测前哨淋巴结阳性乳腺癌患者非前哨淋巴结受累的列线图中。
Ann Surg. 2012 Jan;255(1):109-15. doi: 10.1097/SLA.0b013e318238f461.